Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03661996 · ClinicalTrials.gov registry record · Phase 3
An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA
A Phase 3 study, sponsored by Centrexion Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 854
- Enrollment target
NCT03661996 is a Phase 3 study that has completed, run by Centrexion Therapeutics. The registered enrollment target is 854 participants.
The verdict
NCT03661996, a Phase 3 study, has completed, sponsored by Centrexion Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 854 participants
- Enrollment target
Study Summary
An Open-label, 8-Week Study to Compare the Comfort and Ease of Use of Five Different Treatment Regimens for CNTX 4975-05 Intra-articular Injection in Subjects with Chronic, Moderate-to-Severe Osteoarthritis Knee Pain.
Interventions
- DRUG CNTX-4975-05
- DRUG Lidocaine without epinephrine
- DEVICE ElastoGel
- DEVICE Breg Ice Water Pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 854 participants |
| Start Date | 2018-09-18 |
| Est. Completion | 2019-10-22 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03661996
The ClinicalTrials.gov registry entry for NCT03661996 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 854 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centrexion Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which CNTX-4975-05 is the first listed.
NCT03661996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03661996 about?
NCT03661996 is a clinical study titled "An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA". An Open-label, 8-Week Study to Compare the Comfort and Ease of Use of Five Different Treatment Regimens for CNTX 4975-05 Intra-articular Injection in Subjects with Chronic, Moderate-to-Severe Osteoarthritis Knee Pain.
What is the current status of trial NCT03661996?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 854 participants. The study started on 2018-09-18. Estimated completion is 2019-10-22.
What interventions are being tested in trial NCT03661996?
The interventions under investigation include: CNTX-4975-05 (DRUG), Lidocaine without epinephrine (DRUG), ElastoGel (DEVICE), Breg Ice Water Pump (DEVICE).
Who is sponsoring clinical trial NCT03661996?
This trial is sponsored by Centrexion Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.